-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX THERAPEUTICS INC: PROGRAM TO FOCUS ON TREATMENT OF INDIVIDUALS WHO HAVE GOUT AND ARE INTOLERANT TO ALLOPURINOL

Reuters·01/06/2025 22:18:10

Please log in to view news